Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;25(Suppl 2):S144-S149.
doi: 10.5005/jp-journals-10071-23842.

Typhoid and Enteric Fevers in Intensive Care Unit

Affiliations

Typhoid and Enteric Fevers in Intensive Care Unit

Banambar Ray et al. Indian J Crit Care Med. 2021 May.

Abstract

Enteric fever (typhoid and paratyphoid)is caused by Salmonella typhi and Salmonella paratyphi. It is spread by fecal-oral route, largely through contamination of water and foodstuff. Developing countries are the worst affected. It takes 7 - 21 days from ingestion of the organism to manifestation of symptoms which are generally Fever, relative bradycardia, and pain abdomen. Hepatosplenomegaly, intestinal bleeding, and perforation are the features at various stages of the disease. The bacteria invade the submucous layer and proliferate in the Payer's patches. Blood culture is the gold standard for diagnosis but it is only rarely positive. Fluroquinolones, cephalosporins, and azithromycin are antibiotics of choice. There is increasing evidence of the development of resistance to all antibiotics. Salmonella sepsis, though uncommon, can occur. Intestinal perforation, peritonitis, and secondary sepsis are complications that may require intensive care unit management. How to cite this article: Ray B, Raha A. Typhoid and Enteric Fevers in Intensive Care Unit. Indian J Crit Care Med 2021;25(Suppl 2):S144-S149.

Keywords: Ceftriaxone; Enteric fever; Fever; Fluoroquinolones; Gram-negative bacilli; ICU.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

Figures

Fig. 1
Fig. 1
Pathophysiology of typhoid fever
Fig. 2
Fig. 2
Change in culture-positive cases over time
Fig. 3
Fig. 3
Antibiotics used for the treatment of typhoid in India
Fig. 4
Fig. 4
Complication rates depending on disease onset to hospitalization

References

    1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):P1211–P1259. doi: 10.1016/S0140-6736(17)32154-2. DOI: - DOI - PMC - PubMed
    1. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):P1151–P1210. doi: 10.1016/S0140-6736(17)32152-9. DOI: - DOI - PMC - PubMed
    1. John J, Van Aart CJ, Grassly NC. The burden of typhoid and paratyphoid in India: Systematic review and meta-analysis. PLoSNegl Trop Dis. 2016;10(4):e0004616. doi: 10.1371/journal.pntd.0004616. DOI: - DOI - PMC - PubMed
    1. Lynch MF, Blanton EM, Bulens S, Polyak C, Vojdani J, Stevenson J. Typhoid fever in the United States, 1999–2006. JAMA. 2009;302(8):859–865. doi: 10.1001/jama.2009.1229. DOI: - DOI - PubMed
    1. Cruz Espinoza LM, Mc Creedy E, Holm M, Im J, Mogeni OD, Parajulee P, et al. Occurrence of typhoid fever complications and their relation to duration of illness preceding hospitalization: a systematic literature review and meta-analysis. Clin Infect Dis. 2019;69(Suppl. 6):S435–S448. doi: 10.1093/cid/ciz477. DOI: - DOI - PMC - PubMed

LinkOut - more resources